methaniazide: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 3769 |
| CHEMBL ID | 2105190 |
| CHEBI ID | 134943 |
| SCHEMBL ID | 606355 |
| MeSH ID | M0170242 |
| Synonym |
|---|
| CHEBI:134943 |
| 13447-95-5 |
| methaniazide (inn) |
| D08198 |
| methaniazide |
| [2-(pyridine-4-carbonyl)hydrazinyl]methanesulfonic acid |
| isoniazid methanesulfonate |
| metaniazide |
| unii-gn8s7zes0f |
| methaniazide [inn] |
| methaniazidum [inn-latin] |
| metaniazide [dcit] |
| methaniazidum |
| isonicotinic acid 2-(sulfomethyl)hydrazine |
| gn8s7zes0f , |
| metaniazida [inn-spanish] |
| metaniazida |
| einecs 236-605-3 |
| isoniazide sodium methanesulfonate |
| CHEMBL2105190 |
| methaniazide [who-dd] |
| 4-pyridinecarboxylic acid 2-(sulfomethyl)hydrazide |
| isoniazid methanesulfonate [mi] |
| methaniazide [mart.] |
| SCHEMBL606355 |
| DTXSID2048248 |
| Q27279190 |
| [(pyridin-4-yl)formohydrazido]methanesulfonic acid |
| Class | Description |
|---|---|
| pyridinemonocarboxylic acid | A monocarboxylic acid in which the carboxy group is attached to a pyridine (or substituted pyridine) ring. |
| aromatic carboxylic acid | Any carboxylic acid in which the carboxy group is directly bonded to an aromatic ring. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| USP1 protein, partial | Homo sapiens (human) | Potency | 79.4328 | 0.0316 | 37.5844 | 354.8130 | AID504865 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID504749 | qHTS profiling for inhibitors of Plasmodium falciparum proliferation | 2011 | Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043 | Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 6 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (15.65) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 2 (20.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||